Innovative cancer therapies offer new hope

. 2024 May;629(8014):S1.

doi: 10.1038/d41586-024-01425-6.

Herb Brody. Nature. 2024 May.

. 2024 May;629(8014):S1.

doi: 10.1038/d41586-024-01425-6.

No abstract available

Keywords: Cancer; Diseases; Medical research; Therapeutics.

Similar articles

[TGF-β-targeted immunotherapy aiming for new and efficient treatments of cancer].
Foughali R, Marie JC. Foughali R, et al. Med Sci (Paris). 2020 Jan;36(1):77-79. doi: 10.1051/medsci/2019261. Epub 2020 Feb 4. Med Sci (Paris). 2020. PMID: 32014103 French. No abstract available.
[Non-mutated neoantigens, TEIPP, as new targets for cancer immunotherapies].
Vouilloz A, Serre L. Vouilloz A, et al. Med Sci (Paris). 2020 Jan;36(1):83-86. doi: 10.1051/medsci/2019263. Epub 2020 Feb 4. Med Sci (Paris). 2020. PMID: 32014105 French. No abstract available.
[New treatments in immuno-oncology: a revolution and a formidable scientific and clinical challenge].
Champiat S, Soria JC. Champiat S, et al. Med Sci (Paris). 2017 Jun-Jul;33(6-7):563-564. doi: 10.1051/medsci/20173306001. Epub 2017 Jul 19. Med Sci (Paris). 2017. PMID: 28990546 French. No abstract available.
[New treatments for metastatic melanoma: a first hope].
Robert C, Mateus C. Robert C, et al. Rev Prat. 2011 Nov;61(9 Suppl):S1-2. Rev Prat. 2011. PMID: 22338196 Review. French. No abstract available.
Phase I trials as valid therapeutic options for patients with cancer.
Adashek JJ, LoRusso PM, Hong DS, Kurzrock R. Adashek JJ, et al. Nat Rev Clin Oncol. 2019 Dec;16(12):773-778. doi: 10.1038/s41571-019-0262-9. Epub 2019 Sep 2. Nat Rev Clin Oncol. 2019. PMID: 31477881 Free PMC article. Review.

Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives.
Cerra B, Gioiello A. Cerra B, et al. J Enzyme Inhib Med Chem. 2025 Dec;40(1):2483818. doi: 10.1080/14756366.2025.2483818. Epub 2025 Apr 2. J Enzyme Inhib Med Chem. 2025. PMID: 40172115 Free PMC article. Review.
Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy.
Chen S, Li Y, Zhou Z, Saiding Q, Zhang Y, An S, Khan MM, Ji X, Qiao R, Tao W, Kong N, Chen W, Xie T. Chen S, et al. Sci Adv. 2025 May 23;11(21):eadw7191. doi: 10.1126/sciadv.adw7191. Epub 2025 May 21. Sci Adv. 2025. PMID: 40397726 Free PMC article.